Mulago Hospital, Uganda Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Kampala Uganda (1917)

Organization Overview

First Clinical Trial
2009
NCT01937650
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Mulago Hospital, Uganda | Mulago National Referral Hospital | Mulago NAtional Referral Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 3)

Anemia, Sickle Cell (Phase 3)

Hypertension (Phase 4)

Malaria (Phase 3)

Uterine Cervical Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 8